Building on the resounding success of the last 7 North American Vaccine Forums, the 2010 event will once again provide a highly valuable meeting place for senior level industry and public sector figures driving the development of novel prophylactic and therapeutic vaccines.

The 3 day conference program will feature a mixture of business, regulatory and scientific topics, with speakers drawn from big pharma/biotech, the regulators and and vaccine developers themselves. Breakout sessions, workshops and panel discussions combine to make the event highly interactive.

In 2010, the Washington Vaccine Forum will once again run concurrently with Phacilitate’s annual Cell & Gene Therapy Forum. Participants will be able to select the conference agenda of greatest current value to themselves and their organization, with all networking opportunities shared between the two events. Breakfast and lunch buffets, extended refreshment breaks and evening receptions will all take place in the shared exhibition area.

"Excellent. The best"

Dr Michael Balady, Acting Deputy Director, Medical Countermeasures, Office of Public Health Emergency Medical Countermeasures, Office of the Assistant Secretary for Preparedness & Response (ASPR), US Department of Health & Human Services

A total of 500+ senior level attendees participated in 2009. For more information on how your company can raise it’s profile with both sets of attendees all under one roof and in just three days at the '10 event, please click here.

Please e-mail me when the agenda is live • required
	Title Dr Professor Mr Mrs Ms •
• Name
• Organisation
• Email Address
	Select Your Country Afghanistan Argentina Australia Austria Bahamas Bahrain Bangladesh Belgium Bermuda Brazil Bulgaria Cambodia Canada Chile China Colombia Costa Rica Croatia Cuba Czech Republic Denmark Ecuador Estonia Ethiopia Fiji Finland France Gambia Germany Greece Hong Kong SAR Hungary Iceland India Iran Iraq Ireland Israel Italy Japan Jordan Kenya Kuwait Lebanon Libya Luxembourg Malaysia Mexico Mozambique Netherlands New Zealand Nicaragua Norway Pakistan Peru Poland Portugal Romania Russia Saudi Arabia Singapore South Africa South Korea Spain Sudan Sweden Switzerland Taiwan Thailand Turkey Ukraine United Arab Emirates United Kingdom United States Uruguay Venezuela West Indies Vietnam Zambia Zimbabwe